Glaxo in Trouble over Claims Against Avandia Diabetes Drug

.

Glaxo in Trouble over Claims Against Avandia Diabetes Drug

There have been claims that Avandia diabetes drug is causing high risk of heart attacks and congestive heart failure to the users. And in this regard, around four Lawsuits have been filed in the UK against the producer, GlaxoSmithKline Plc (GSK).

Avandia was once known as the world's best diabetes pill but now has been surrounded amid several claims.

Daniel Slade is the lawyer involved and he is representing consumers in four lawsuits. In addition, there are 15 more clients in his list of this case. As revealed by him, the potential number of claims against GSK seems to go higher in a short period of time.

He commented during a telephonic interview: "We expect the number of claims to increase as there are potentially thousands of people out there who took Avandia in the U. K. Hopefully these claims will lead to more careful studies and checks on drugs that are widely marketed".

To settle down the claims of marketing Avandia along with other medication in an illegal manner; Glaxo had already paid more than $3 billion to the U. S. federal and state government.

David Daley, a spokesman for Brentford, UK-based Glaxo, while sympathizing with people suffering from health complications related with diabetes said that the company is bound to comment over any such cases.

 


Latest News

New details emerge in Jerry Sandusky sex abuse scandal
Wal-Mart’s Total Sales Drop; The Retailer will Introduce its ‘Door-Greeter’ Prog
Two Fire Incidents in Federal Center SW Station Leads to a Shut Down
Increasing Number of Car Makers Collaborating with Tech Companies to Develop Sel
Mortgage Rates Move Back Close to Its Yearly Low
Fire threatens entire city in Alberta
George Bush to stay out of the presidential campaign
Teen Retailer Aeropostale Files for Bankruptcy Protection; Closing Twenty Percen
Zynga’s Q1 Earnings Repot Beats Analysts’ Estimates
Tribune Publishing Says ‘No’ to Gannett Company’s Takeover Offer
Tesla Motors Posts Loss in the First Quarter that’s Larger than Last Year